MRI-derived Pressure Ratio (MPR) to predict stroke risk in intracranial atherosclerosis (ICAS)
Official title: MRI-Derived Pressure Ratio: a Novel Noninvasive Hemodynamic Biomarker for Stroke Risk Stratification in Intracranial Atherosclerotic Stenosis
Run by Xuanwu Hospital, Beijing · NCT07309718 · Data updated 2026-11-12
This study will test whether a new MRI-derived pressure ratio (MPR) can help predict 1-year stroke risk in adults (18–80) with 50–99% intracranial atherosclerotic stenosis in the anterior circulation.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 400 (estimated) |
| Sponsor | Xuanwu Hospital, Beijing Academic / other |
| Locations | 1 site (Beijing, Xicheng District) |
| Status | Recruiting |
| Started | December 1, 2025 |
| Main results expected | December 15, 2027 |
| Study ends | March 31, 2028 |
| Registry record updated | December 30, 2025 |
| Trial ID | NCT07309718 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–80 with symptomatic anterior-circulation intracranial atherosclerotic stenosis of 50–99% who can undergo MRI and give informed consent are the ideal candidates.
✕Probably not a fit
Patients with non-atherosclerotic intracranial disease, large baseline infarcts or baseline disability (mRS ≥3), contraindications to MRI, or significant ipsilateral extracranial carotid stenosis are unlikely to benefit from MPR measurement in this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a multicenter prospective single-arm registry enrolling 400 consecutive adults with symptomatic anterior-circulation ICAS and 50–99% stenosis. All participants receive standardized medical therapy per AHA/ASA guidelines and undergo multimodal imaging including TCD, CTA/MRA/DSA, high-resolution MRI, and phase-contrast MRA to calculate MPR. Participants are followed at baseline, 1 month, 6 months, and 12 months, with the primary outcome of ischemic stroke in the qualifying artery territory or related death within one year. An independent DSMB oversees safety and study conduct across five participating stroke centers coordinated by Xuanwu Hospital in Beijing.
Why it matters
Potential benefit: If successful, MPR could help doctors identify which patients with ICAS are at higher short-term stroke risk and guide more personalized prevention strategies.
How similar studies have gone: Pressure-based hemodynamic approaches are well established in coronary disease and have shown promise in limited neurovascular research, but MPR as an MRI-derived intracranial pressure ratio is a relatively novel application with limited prior large-scale validation.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adults aged 18 to 80 years. 2. Intracranial atherosclerotic stenosis ICAS involving a culprit artery in the anterior circulation. 3. Intracranial arterial stenosis of 50% to 99% as measured by the WASID method using TCD, CTA, MRA, or DSA. 4. Written informed consent obtained from the participant or a legal representative. Exclusion Criteria: 1. Non-atherosclerotic intracranial lesions, including moyamoya disease, vasculitis, vascular dissection, autoimmune diseases, or congenital/genetic abnormalities. 2. More than 50% stenosis of the extracranial carotid artery on the ipsilateral side. 3. Large cerebral infarction involving more than one-half of the territory on DWI imaging, or a baseline modified Rankin Scale score ≥3. 4. Contraindications to antiplatelet therapy or statins. 5. Inability to undergo MRI due to metal implants or claustrophobia.
Where it's running
-
Department of Neurosurgery, Xuanwu hospital
Beijing, Xicheng District, China Recruiting
Study contacts
- Study coordinator: Jichang Luo, M.D.
- Email: luojichang_dr@sina.com
- Phone: +86 13120136577
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Paired VNS: How the Brain and Pupils Respond in Stroke Patients
This study tests real-time physiologic responses to paired VNS in adults with chronic motor impairment after ischemic stroke to help tailor dosing.
-
NeuroAiD test in mild to moderate ischemic stroke patients
This study tests whether adding MLC901 (NeuroAiD II) to standard stroke care helps adults who recently had an ischemic stroke recover better than standard care alone.
-
Hemodynamic Changes and Trigeminocardiac Reflex During Bimaxillary Orthognathic Surgery
This study tests how blood pressure, heart rate, and oxygen levels change during bimaxillary orthognathic surgery and whether the trigeminocardiac reflex occurs.
-
Using IMPROVE to guide carotid revascularisation decisions
This trial tests whether using the IMPROVE MRI-based score to select patients for carotid revascularisation is as good as standard care based mainly on stenosis degree, among people who have had a recent stroke or TIA due to carotid disease.
-
Sedation with dexmedetomidine, propofol, or both during cataract surgery
This project will test whether dexmedetomidine, propofol, or their combination (each given with fentanyl) provides the best sedation, safety, and surgeon satisfaction for adults having cataract surgery.
-
High-intensity interval versus moderate continuous exercise for stroke-related muscle loss
This will test whether high-intensity interval training (HIIT) or moderate-intensity continuous training (MCIT) better helps people 1–6 months after an ischemic stroke who have muscle loss regain muscle mass, strength, walking ability, and quality of life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.